CONTROL OF COMMUNICABLE DISEASES

(DOH PHILIPPINES) DOH-PROGRAMS IN THE CONTROL OF SPECIFIC

COMMUNICABLE DISEASES:
COMMUNICABLE DISEASES National TB (TUBERCULOSIs) Control Program
https://www.doh.gov.ph/malaria-control-program
Contagious Disease- "direct physical contact" Vision
Infectious Disease- transmitted indirectly through: TB -free Philippines
contaminated food, body fluids, objects, airborne inhalation, Mission
or through vector • To reduce TB burden (TB incidence and TB mortality)
organisms • To achieve catastrophic cost of TB-affected households
• To responsively deliver TB service
EPIDEMIOLOGIC TRIANGLE MODEL Program Components
Agent-an organism involved in the development of a disease • Health Promotion
Host-any organism that harbors and provide nutrition for the • Financing and Policy
agent • Human Resource
Environment-refers to the condition in which the agent may • Information System
exist, survive or originate • Regulation
• Service Delivery
ULTIMATE GOAL: ELIMINATION AND ERADICATION • Governance
RA 10767 : Comprehensive TB Elimination Plan Act of 2016
ITFDE (International Task Force for Disease Eradication)
National Leprosy Control Program
TARGETED DISEASES AS MANDATED BY WHO& DOH https://www.doh.gov.ph/leprosy-control-program
PHILIPPINES The National Leprosy Control Program (NLCP) is a multi-
• Tuberculosis agency effort to control Leprosy in the country with private
• Leprosy and public partnership in achieving its goals to lessen the
• Malaria burden of the disease and its mission to have a leprosy-free
• Filariasis country.
• Rabies VISION
• STDIHIVIAIDS Leprosy-free Philippines by the year 2022
• Dengue MISSION
• Schistosomiasis To ensure the provision of comprehensive, integrated quality
leprosy services at all levels of healthcare
FUNCTIONS OF THE PUBLIC HEALTH NURSE IN
THE CONTROL OF COMMUNICABLE DISEASES: OBJECTIVES
1. Report immediately to the Municipal Health Office • To further reduce the disease burden and sustain
any known case of notifiable disease. provision of high-quality leprosy services for all affected
2. Refer immediately to the nearest hospital communities ensuring that the principle of equity and
3. Conduct a strong health education program directed social justice are followed
toward prevention of an outbreak. • To decrease by 50% the identified hyper endemic cities
4. Assist in the diagnosis of the suspect based on the and municipalities
signs and symptoms PROGRAM COMPONENTS
5. Conduct epidemiologic investigations as a means of • Early diagnosis and treatment
contacting families case finding and individual as well • Integration of leprosy services
as Community health education. • Referral system
• Case detection and diagnosis
• Advocacy and IEC focusing on stigma discrimination
and reduction
• Prevention of Deformity, self-care and rehabilitation
• Recording and reporting
• Monitoring, supervision and evaluation
Malaria Control Program
https://www.doh.gov.ph/malaria-control-program
Malaria is a life-threatening disease caused by plasmodium
parasites transmitted by anopheles mosquito or rarely
through blood transfusion and sharing of contaminated
needles causing acute febrile illness and symptoms in the
form of fever, headache and chills. Untreated, P. falciparum
malaria may progress to severe illness and possibly, death.
DOH-NMCEP aims to eliminate malaria by adopting a health
system focused approach to achieve universal coverage with
quality-assured malaria diagnosis and treatment, strengthen
governance and human resources, maintain the financial
support needed, and ensure timely and accurate information
management.
Currently, only 7 provinces remain with local transmission of
the disease. One of these provinces is Palawan, which holds
more than 90% of the country’s malaria cases.
VISION
A Malaria–Free Philippines by 2030
MISSION
Further accelerate malaria control and transition towards
elimination
OBJECTIVES
1. (Universal Access) – To ensure universal access to reliable
diagnosis, highly effective and appropriate treatment and
preventive measures
2.(Governance and Human Resources) – To strengthen
governance and human resources capacity at all levels to
manage and implement malaria interventions
3. (Health Financing) – To secure government and non-
government financing to sustain malaria control and
elimination efforts at all levels
4. (Health Information and Regulation) – To ensure quality
malaria services, timely detection of infection and immediate
response, and information and evidence to guide malaria
elimination
PROGRAM COMPONENTS
• Program Management and Health System -
• Diagnosis and Treatment
• Vector Control
• Advocacy and Social Mobilization
• Surveillance, Outbreak Preparedness and Response
• Monitoring and Evaluation
• Partnerships
• Assessment of Other Factors
Filariasis Elimination Program
https://www.doh.gov.ph/national-filariasis-elimination-
program
The Elimination started in 2001 after a pilot study using the
combination drugs in 2000 in five selected municipalities in
five provinces.
Total no. of province: 81
Total population in the country: 103, 741, 330 as of 2018
Total Endemic Provinces: 46 Provinces in 12 Regions
Total Endemic Population: 8 Million
Parasite: Majority is Wuchereria bancrofti
Vectors incriminated: Aedes poecilius, Anopheles flavirostris
VISION
Healthy and productive individuals and families for Filariasis-
Free Philippines
MISSION
Elimination of Filariasis as a public health problem thru
comprehensive approach and universal access to quality
health services
OBJECTIVES
• To sustain transmission interruption in provinces through
strengthening of surveillance
• To intensify interventions and interrupt transmission in
persistent infection provinces
• To strengthen Morbidity Management & Disability
Prevention (MMDP) activities and services to alleviate
suffering among chronic patients
• To strengthen the health system capacity to secure LF
elimination
• Secure adequate investment from governmental and
non-governmental sources to sustain all program
objective
PROGRAM COMPONENTS
Filariasis is a major parasitic infection, which continues to be
a public health problem in the Philippines. It was first
discovered in the Philippines in 1907 by foreign workers.
Consolidated field reports showed a prevalence rate of 9.7%
per 1000 population in 1998. It is the second leading cause of
permanent and long-term disability. The disease affects
mostly the poorest municipalities in the country about 76% of
the case live in the 4th-6th class type of municipalities.
The World Health Assembly in 1997 declared “Filariasis
Elimination as a priority” where the WHO’s call for global
elimination was created (WHA 50.29 Resolution: Elimination
of lymphatic filariasis as a public health problem). This was
followed by the Global Program for Elimination of Lymphatic
Filariasis, launched by World Health Organization which has
two main components that were adopted by the national
program:
• INTERRUPTION OF TRANSMISSION: Elimination level 2. Adolescent females
prevalence of microfilaremia of less than 1% and Antigen Albendazole 400 mg once a year
rate of < 1% through Mass Drug Administration (MDA) Mebendazole 500 mg once a year
• CONTROL AND REDUCE THE MORBIDITY by alleviating the
sufferings and disability caused by its clinical 3. Pregnant women
manifestations through Morbidity Management t is recommended that all pregnant women who consult the
Disability Prevention (MMDP) health be given anthelminthic drug once in the 2nd trimester
A major strategy of the Elimination Plan was the Mass Annual of
Treatment using the combination drug, Diethylcarbamazine pregnancy. In areas where hookworm is endemic:
Citrate and Albendazole for a minimum of 5 years to Where hookworm prevalence is 20-30%
individuals ages 2 years old and above living in established Albendazole 400 mg once In the 2nd trimester
endemic areas after the issuance from WHO of the safety Mebendazole 500 mg once in the 2nd trimester
data on the use of the drugs. The Philippine Plan was Where hookworm prevalence is > 50%,
approved by WHO which gave the government free supply of repeat treatment in the 3rd Trimester
the Albendazole (donated by GSK thru WHO) for filariasis
elimination. An Administrative Order declaring “November as 4.Special groups, e.g., food handlers and operators, soldiers,
Filariasis Mass Treatment Month was signed by the Secretary farmers and indigenous people. Selective deworming is the
of Health was issued on that same year. In 2010, a guideline giving of anthelminthic drug to an individual based on the
in the prevention of disabilities due to lymphatic Filariasis indiagnosis of current infection. However, certain groups of
support to effective implementation of management of people should be given deworming drugs regardless of their
morbidity and prevention of disabilities due to Filariasis status once they consult the health center. Special groups like
soldiers, famers, food handlers and operators, and
Indigenous people are at risk of morbidity because of their
HCP interventions: exposure to different intestinal parasites in relation to their
1 Chemotherapy remains as the core package in helminth occupation or cultural practices. For the clients who will be
infection control dewormed selectively, treatment shall given
2 Water, sanitation and hygiene (WASH) Serves as the be anytime at the health centers.
cornerstone in reducing the prevalence of worm infection
3. Promotion of desired behaviors ensures that these efforts
on chemotherapy and WASH are translated into actual National Safe Motherhood Program
healthy practices and better utilization of these facilities. https://www.doh.gov.ph/national-safe-motherhood-
• Enabling mechanisms must therefore be established to program
Support their implementation. An enabling environment Vision
entails good governance of the IHCP at all levels of operations For Filipino women to have full access to health services
towards making their pregnancy and delivery safer
Targets and Doses Mission
1.Children aged 1 year to 12 years old Guided by the Department of Health FOURmula One Plus
For children 12-24 months old thrust and the Universal Health Care Frame, the National Safe
>Albendazole-200 mg. single dose every 6 months. Since the Motherhood Program is committed to provide rational and
preparation is 400mg, the tablet is halve and can be chewed responsive policy direction to its local government partners
by the child or taken with a glass of water in the delivery of quality maternal and newborn health
Mebendazole 500 mg, single dose every 6 months services with integrity and accountability using proven and
For children 24 months old and above innovative approaches
Albendazole-400 mg, single dose every 6 months
Mebendazole-500 mg, single dose every 6 months
Note: f Vitamin A and deworming drug are given
simultaneously during the GPactlvity, elther drug
can be given first.
 ❖ 31 Training Centers that provide BEmONC Skills Training
• Monitoring, Evaluation, Research, and Dissemination
Objectives with support from the Epidemiology Bureau and Health
The Program contributes to the national goal of improving Policy Development and Planning Bureau
women’s health and well-being by: ❖ Monitoring and Supervision of Private Midwife Clinics in
• Collaborating with Local Government Units in cooperation with PRC Board of Midwifery and
establishing sustainable, cost-effective approach of Professional Midwifery Organizations
delivering health services that ensure access of ❖ Maternal Death Reporting and Review System in
disadvantaged women to acceptable and high quality collaboration with Provincial and City Review Teams
maternal and newborn health services and enable them ❖ Annual Program Implementation Reviews with Provincial
to safely give birth in health facilities near their homes Health Officers and Regional Coordinators
• Establishing core knowledge base and support systems
that facilitate the delivery of quality maternal and
newborn health services in the country.
Program Components
Component A: Local Delivery of the Maternal–Newborn
Service Package
-This component supports LGUs in establishing and mobilizing
the service delivery network of public and private providers
to enable them to deliver the integrated maternal-newborn
service package. In each province and city, the following shall
continue to be undertaken:
• Establishment of critical capacities to provide quality
maternal-newborn services through the organization and
operation of a network of Service Delivery Teams
consisting of:
❖ Barangay Health Workers
❖ BEmONC Teams composed of Doctors, Nurses and
Midwives
• In collaboration with the Centers for health Development
and relevant national offices: Establishment of Reliable
Sustainable Support Systems for Maternal-Newborn
Service Delivery through such initiatives as:
❖ Establishment of Safe Blood Supply Network with
support from the National Voluntary Blood Program
❖ Behavior Change Interventions in collaboration with the
Health Promotion and Communication Service
❖ Sustainable financing of maternal - newborn services
and commodities through locally initiated revenue
generation and retention activities including PhilHealth
accreditation and enrolment.
Component B: National Capacity to Sustain Maternal-
Newborn Services
• Operational and Regulatory Guidelines
❖ Identification and profiling of current FP users and
identification of potential FP clients and those with
unmet need for FP (permanent or temporary methods)
❖ Mainstreaming FP in the regions with high unmet need
for FP
❖ Development and dissemination of Information,
Education Communication materials
❖ Advocacy and social mobilization for FP
• Network of Training Providers